Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Adherence to statins is associated with reduced incidence of idiopathic venous thromboembolism: real-life data from a large healthcare maintenance organisation.

Rabinowich L, Steinvil A, Leshem-Rubinow E, Berliner S, Zeltser D, Rogowski O, Shalev V, Raz R, Chodick G.

Heart. 2012 Dec;98(24):1817-21. doi: 10.1136/heartjnl-2012-302906. Epub 2012 Oct 4.

PMID:
23038788
2.

Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.

Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.

Clin Ther. 2008 Nov;30(11):2167-79. doi: 10.1016/j.clinthera.2008.11.012.

PMID:
19108805
3.

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.

PMID:
20206788
4.

Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism.

Resh M, Mahmoodi BK, Navis GJ, Veeger NJ, Lijfering WM.

Thromb Res. 2011 May;127(5):395-9. doi: 10.1016/j.thromres.2010.12.020. Epub 2011 Jan 31.

PMID:
21277007
5.

Venous thromboembolism after major orthopaedic surgery: a population-based cohort study.

Imberti D, Bianchi C, Zambon A, Parodi A, Merlino L, Gallerani M, Corrao G.

Intern Emerg Med. 2012 Jun;7(3):243-9. doi: 10.1007/s11739-011-0567-x. Epub 2011 Mar 26.

PMID:
21442184
6.

Statins decrease the occurrence of venous thromboembolism in patients with cancer.

Khemasuwan D, Divietro ML, Tangdhanakanond K, Pomerantz SC, Eiger G.

Am J Med. 2010 Jan;123(1):60-5. doi: 10.1016/j.amjmed.2009.05.025.

PMID:
20102993
7.

The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study.

Lassila R, Jula A, Pitkäniemi J, Haukka J.

BMJ Open. 2014 Nov 5;4(11):e005862. doi: 10.1136/bmjopen-2014-005862.

8.

Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.

Haut ER, Lau BD, Kraenzlin FS, Hobson DB, Kraus PS, Carolan HT, Haider AH, Holzmueller CG, Efron DT, Pronovost PJ, Streiff MB.

Arch Surg. 2012 Oct;147(10):901-7. doi: 10.1001/archsurg.2012.2024.

PMID:
23070407
9.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
11.

Rates of venous thromboembolism occurrence in medical patients among the insured population.

Spyropoulos AC, Hussein M, Lin J, Battleman D.

Thromb Haemost. 2009 Nov;102(5):951-7. doi: 10.1160/TH09-02-0073.

PMID:
19888534
12.

When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.

Duska LR, Garrett L, Henretta M, Ferriss JS, Lee L, Horowitz N.

Gynecol Oncol. 2010 Mar;116(3):374-7. doi: 10.1016/j.ygyno.2009.10.069.

PMID:
19922988
13.

Men had a higher risk of recurrent venous thromboembolism than women: a large population study.

Tagalakis V, Kondal D, Ji Y, Boivin JF, Moride Y, Ciampi A, Kahn SR.

Gend Med. 2012 Feb;9(1):33-43. doi: 10.1016/j.genm.2011.12.002.

PMID:
22333521
14.

Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.

Vekeman F, LaMori JC, Laliberté F, Nutescu E, Duh MS, Bookhart BK, Schein J, Dea K, Olson WH, Lefebvre P.

J Med Econ. 2011;14(3):324-34. doi: 10.3111/13696998.2011.578698. Epub 2011 Apr 20.

PMID:
21506632
15.

The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer.

Lee KW, Bang SM, Kim S, Lee HJ, Shin DY, Koh Y, Lee YG, Cha Y, Kim YJ, Kim JH, Park DJ, Kim HH, Oh D, Lee JS.

J Thromb Haemost. 2010 Mar;8(3):540-7. doi: 10.1111/j.1538-7836.2009.03731.x. Epub 2009 Dec 21.

16.

Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.

Degli Esposti L, Saragoni S, Batacchi P, Benemei S, Geppetti P, Sturani A, Buda S, Degli Esposti E.

Clin Ther. 2012 Jan;34(1):190-9. doi: 10.1016/j.clinthera.2011.12.011.

PMID:
22284998
17.

Dose-related effect of statins in venous thrombosis risk reduction.

Khemasuwan D, Chae YK, Gupta S, Carpio A, Yun JH, Neagu S, Lucca AB, Valsecchi ME, Mora JI.

Am J Med. 2011 Sep;124(9):852-9. doi: 10.1016/j.amjmed.2011.04.019. Epub 2011 Jul 21.

PMID:
21783169
18.

Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage.

Kim KS, Brophy GM.

Neurocrit Care. 2009;11(1):28-33. doi: 10.1007/s12028-009-9201-4. Epub 2009 Feb 24.

PMID:
19238588
19.

Effect of statin adherence on cerebrovascular disease in primary prevention.

Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L.

Am J Med. 2009 Jul;122(7):647-55. doi: 10.1016/j.amjmed.2009.01.032.

PMID:
19559167
20.

Evidence-based venous thromboembolism prophylaxis is associated with a six-fold decrease in numbers of symptomatic venous thromboembolisms in rehabilitation inpatients.

Mayer RS, Streiff MB, Hobson DB, Halpert DE, Berenholtz SM.

PM R. 2011 Dec;3(12):1111-1115.e1. doi: 10.1016/j.pmrj.2011.07.022.

PMID:
22192320

Supplemental Content

Support Center